Abstract
In this work we studied the tumor effect of fructose and glucose on the mice xenotransplant model of sarcoma 180 (S180) in in vivo. The experimental results suggest that for dosages of 14 mg/kg and 28 mg/kg glucose (and fructose in a lower rate) show a great inhibitory behavior on tumors.
Keywords: Fructose, glucose, tumors, phenotypes, metabolism, ether, diabetics, tree fruits, melons
Letters in Organic Chemistry
Title: A Comparative Study of Glucose and Fructose in the Development of Sarcoma 180 in Mice
Volume: 8 Issue: 8
Author(s): G. S. Paiva, Carlton A. Taft and Ivone A. de Souza
Affiliation:
Keywords: Fructose, glucose, tumors, phenotypes, metabolism, ether, diabetics, tree fruits, melons
Abstract: In this work we studied the tumor effect of fructose and glucose on the mice xenotransplant model of sarcoma 180 (S180) in in vivo. The experimental results suggest that for dosages of 14 mg/kg and 28 mg/kg glucose (and fructose in a lower rate) show a great inhibitory behavior on tumors.
Export Options
About this article
Cite this article as:
S. Paiva G., A. Taft Carlton and A. de Souza Ivone, A Comparative Study of Glucose and Fructose in the Development of Sarcoma 180 in Mice, Letters in Organic Chemistry 2011; 8 (8) . https://dx.doi.org/10.2174/157017811797249407
DOI https://dx.doi.org/10.2174/157017811797249407 |
Print ISSN 1570-1786 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6255 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Protein Kinase C as a Drug Target Implications for Drug or Diet Prevention and Treatment of Cancer
Current Drug Targets Radiopharmaceutical: Revolutionary Agents for Diagnosis
Current Radiopharmaceuticals The Role of Mammalian Target of Rapamycin (mTOR) Inhibitors in the Treatment of Solid Tumors
Current Cancer Therapy Reviews Aspartic Protease Inhibitors as Potential Anti-Candida albicans Drugs: Impacts on Fungal Biology, Virulence and Pathogenesis
Current Medicinal Chemistry T Cell Tuning for Tumour Therapy: Enhancing Effector Function and Memory Potential of Therapeutic T cells
Current Gene Therapy The Heat Shock Protein 90 Chaperone Complex: An Evolving Therapeutic Target
Current Cancer Drug Targets Response to HAART in Treatment-Naive HIV-Infected Patients with a Prior Diagnosis of Tuberculosis or other Opportunistic Infections
Current HIV Research Nuclear Magnetic Resonance Spectroscopy of Lipids in Cancer
Current Organic Chemistry Dendrimers in Therapy for Breast and Colorectal Cancer
Current Medicinal Chemistry <sup>109</sup>Pd labeled 5,10,15,20-tetrakis[4-carboxymethyleneoxyphenyl]porphyrin: a Potential Agent for Targeted Tumor Therapy
Current Radiopharmaceuticals Prodrugs in Photodynamic Anticancer Therapy
Current Pharmaceutical Design The Quest for a Tumor Suppressor Gene Phenotype
Current Molecular Medicine Role of Infrared Spectroscopy and Imaging in Cancer Diagnosis
Current Medicinal Chemistry Anti-Inflammatory Activity of Tetracyclines: Applications to Human Disease
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Imaging Features of Carcinosarcoma Arising from Adenofibroma of the Uterus: A Case Report
Current Medical Imaging The Cell Wall-Associated Proteins in the Dimorphic Pathogenic Species of Paracoccidioides
Current Protein & Peptide Science Targeting Protein-Protein Interaction with Covalent Small-Molecule Inhibitors
Current Topics in Medicinal Chemistry Potential Therapeutic Benefits of Maintaining Mitochondrial Health in Peripheral Neuropathies
Current Neuropharmacology Diffusion-Weighted Imaging in Abdominal Oncology
Current Medical Imaging Anticancer Drug Combinations, How Far We can Go Through?
Anti-Cancer Agents in Medicinal Chemistry